·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊÆ÷ÀÎÆ®¸ôTVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ·¹°íÄÍ, ¾ÏÁ¨¿¡ ½Å¾à Ç÷§Æû ±â¼úÀÌÀü...ÃÖ´ë 1.6Á¶¿ø ±â»çÀÔ·Â : 22.12.23 07:56:13 0 °¡ ÇÃÄ£Ãß°¡ ADC Ç÷§Æû ±â¼ú 5°³ Ÿ±ê Ä¡·áÁ¦ ±ÇÇÑ ÀÌÀü...°è¾à±Ý ºñ°ø [µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] ·¹°íÄ͹ÙÀÌ¿À»çÀ̾𽺴 ±Û·Î¹úÁ¦¾à»ç ¾ÏÁ¨°ú Ç×ü ¾à¹° º¹ÇÕÁ¦(ADC) Ç÷§Æû ±â¼úÀ» ±â¼úÀÌÀüÇß´Ù°í 23ÀÏ °ø½ÃÇß´Ù. À̹ø °è¾àÀ» ÅëÇØ ·¹°íÄ͹ÙÀÌ¿À´Â ±â¼úÀÌ¿ë·á, Àӻ󰳹ߡ¤Çã°¡, »ó¾÷È ¸¶ÀϽºÅæÀ» Æ÷ÇÔÇØ ÃÖ´ë1¾ï2475¸¸´Þ·¯(1Á¶6050¾ï¿ø)°ú ¸ÅÃâ¾×¿¡ µû¸¥ º°µµÀÇ ·Î¿Æ¼¸¦ ¹Þ°Ô µÈ´Ù. °è¾à±Ý ±Ô¸ð´Â °ø°³µÇÁö ¾Ê¾Ò´Ù. ¾ÏÁ¨Àº ÀÚü º¸À¯ Ç×ü¿Í ·¹°íÄ͹ÙÀÌ¿ÀÀÇ Â÷¼¼´ë ADCÇ÷§Æû ±â¼úÀ» È°¿ëÇØ 5°³ Ÿ±ê ´ë»ó ADCÄ¡·áÁ¦ÀÇ ±Û·Î¹ú °³¹ß°ú »ó¾÷È ±Ç¸®¸¦ °®´Â´Ù. ¾ÏÁ¨¿¡ ÀÌÀüµÈ ·¹°íÄ͹ÙÀÌ¿ÀÀÇ ÀÓ»ó´Ü°è ADCÇ÷§Æû ±â¼úÀº ¾Ï¼¼Æ÷ ³»¿¡¼ ¼±ÅÃÀûÀ¸·Î È°¼ºÈµÇ°í Ç×üÀÇ Æ¯Á¤ºÎÀ§ Á¢ÇÕ¿¡ ÃÖÀûÈµÈ °áÇÕ¹æ¹ýÀ¸·Î ±¸¼ºµÈ ±â¼úÀÌ´Ù. ±âÁ¸ ±â¼ú ´ëºñ ³ôÀº È¿´É°ú ³·Àº ºÎÀÛ¿ë ±×¸®°í Ź¿ùÇÑ Ç÷Áß ¾ÈÁ¤¼º µîÀÇ Â÷º°ÈµÈ ÀåÁ¡À» º¸À¯Çß´Ù´Â Æò°¡´Ù. ±è¿ëÁÖ ·¹°íÄ͹ÙÀÌ¿À ´ëÇ¥ÀÌ»ç´Â ¡°¾ÏÁ¨Àº ¼±µµÀûÀÎ Ç×¾ÏÄ¡·áÁ¦¸¦ ½ÃÀå¿¡ ¼±º¸ÀÌ°í ÀÖ´Â ´ëÇ¥ÀûÀÎ ±Û·Î¹úÁ¦¾à»ç·Î À̹ø Â÷¼¼´ë ADCÄ¡·áÁ¦ °³¹ß¿¡ ´ç»ç ADC±â¼úÀÌ ¼±ÅÃµÇ¾î ¸Å¿ì ±â»Ú´Ù¡±¶ó¸é¼ ¡°À̹ø °è¾àÀ» °è±â·Î ÇâÈÄ ±Û·Î¹úÁ¦¾à»ç Áß½ÉÀ¸·Î ÆÄÆ®³Ê½ÊÀ» È®´ëÇÔ°ú µ¿½Ã¿¡ ÀÚü ADC ÆÄÀÌÇÁ¶óÀεµ °ÈÇÏ¸é¼ ¼ºÀåÀ» °¡¼ÓÈ ÇØ ³ª°¥ °ÍÀÌ´Ù¡±¶ó°í ¸»Çß´Ù. õ½ÂÇö ±âÀÚ(1000@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [»ï¿ø¾àÇ° ¿ï»êÁöÁ¡] °ü¸®¾à»ç´Ô ¸ðÁý°ø°í ¹Ù·Î°¡±â [ÇÏ¿ìÅõ¾à] ºê·£µå/Ç÷§Æû ¿î¿µ Àü·« ±âȹ ¾à»ç ÀÎÅÏ ¸ðÁý ¹Ù·Î°¡±â Sr. Medical Affairs Scientist ¹Ù·Î°¡±â Sr. Clinical Operations Manager ¹Ù·Î°¡±â Market Access Manager ¹Ù·Î°¡±â ¿µ¾÷ / training / compliance / admin ¹Ù·Î°¡±â MSL GM CVT (À°¾ÆÈÞÁ÷´ëü 1³â °è¾àÁ÷) ¹Ù·Î°¡±â PV ±×·ì ¹× ½Ã¼³±×·ì ä¿ë ¹Ù·Î°¡±â 2024 ¾à´ë½ÉȽǽÀ, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â RA, BD, ¿µ¾÷, °øÀå µî ÀüºÎ¹® ä¿ë ¹Ù·Î°¡±â [ºñŸ¹ÎÇϿ콺] ¾à»ç °æ·ÂÁ÷ ä¿ë ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à»ç ä¿ë(Çѱ¹ÀǾàÇ°¾ÈÀü°ü¸®¿ø 24³â 3Â÷ ä¿ë) ¹Ù·Î°¡±â MSL Radiology ¹Ù·Î°¡±â [Çѱ¹¿ÀÃ÷Ä«Á¦¾à] Clinical Trial Manager(1~3»ó) ¹Ù·Î°¡±â (´ëÀü/Ãæû) ¿µ¾÷ºÎ °æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â [¾Ëº¸Á¨ÄÚ¸®¾Æ] Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â º¹»ê³ªÀ̽º ºÎ»ê°ü¸®¾à»ç (ºÎ»êÅëÇÕ¹°·ù¼¾ÅÍ) ¹Ù·Î°¡±â ¿ø·áÀǾàÇ° µµ¸Å, ¼öÀÔ°ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â ȯÀÎÁ¦¾à(ÁÖ) 5¿ù ¼ö½Ãä¿ë(5/7(¿ù)~5/27(¿ù) 13:30±îÁö) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ·¹°íÄÍ, ¾ÏÁ¨¿¡ ½Å¾à Ç÷§Æû ±â¼úÀÌÀü...ÃÖ´ë 1.6Á¶¿ø URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ·¹°íÄÍ, ¾ÏÁ¨¿¡ ½Å¾à Ç÷§Æû ±â¼úÀÌÀü...ÃÖ´ë 1.6Á¶¿ø ±â»çÀÔ·Â : 22.12.23 07:56:13 0 °¡ ÇÃÄ£Ãß°¡ ADC Ç÷§Æû ±â¼ú 5°³ Ÿ±ê Ä¡·áÁ¦ ±ÇÇÑ ÀÌÀü...°è¾à±Ý ºñ°ø [µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] ·¹°íÄ͹ÙÀÌ¿À»çÀ̾𽺴 ±Û·Î¹úÁ¦¾à»ç ¾ÏÁ¨°ú Ç×ü ¾à¹° º¹ÇÕÁ¦(ADC) Ç÷§Æû ±â¼úÀ» ±â¼úÀÌÀüÇß´Ù°í 23ÀÏ °ø½ÃÇß´Ù. À̹ø °è¾àÀ» ÅëÇØ ·¹°íÄ͹ÙÀÌ¿À´Â ±â¼úÀÌ¿ë·á, Àӻ󰳹ߡ¤Çã°¡, »ó¾÷È ¸¶ÀϽºÅæÀ» Æ÷ÇÔÇØ ÃÖ´ë1¾ï2475¸¸´Þ·¯(1Á¶6050¾ï¿ø)°ú ¸ÅÃâ¾×¿¡ µû¸¥ º°µµÀÇ ·Î¿Æ¼¸¦ ¹Þ°Ô µÈ´Ù. °è¾à±Ý ±Ô¸ð´Â °ø°³µÇÁö ¾Ê¾Ò´Ù. ¾ÏÁ¨Àº ÀÚü º¸À¯ Ç×ü¿Í ·¹°íÄ͹ÙÀÌ¿ÀÀÇ Â÷¼¼´ë ADCÇ÷§Æû ±â¼úÀ» È°¿ëÇØ 5°³ Ÿ±ê ´ë»ó ADCÄ¡·áÁ¦ÀÇ ±Û·Î¹ú °³¹ß°ú »ó¾÷È ±Ç¸®¸¦ °®´Â´Ù. ¾ÏÁ¨¿¡ ÀÌÀüµÈ ·¹°íÄ͹ÙÀÌ¿ÀÀÇ ÀÓ»ó´Ü°è ADCÇ÷§Æû ±â¼úÀº ¾Ï¼¼Æ÷ ³»¿¡¼ ¼±ÅÃÀûÀ¸·Î È°¼ºÈµÇ°í Ç×üÀÇ Æ¯Á¤ºÎÀ§ Á¢ÇÕ¿¡ ÃÖÀûÈµÈ °áÇÕ¹æ¹ýÀ¸·Î ±¸¼ºµÈ ±â¼úÀÌ´Ù. ±âÁ¸ ±â¼ú ´ëºñ ³ôÀº È¿´É°ú ³·Àº ºÎÀÛ¿ë ±×¸®°í Ź¿ùÇÑ Ç÷Áß ¾ÈÁ¤¼º µîÀÇ Â÷º°ÈµÈ ÀåÁ¡À» º¸À¯Çß´Ù´Â Æò°¡´Ù. ±è¿ëÁÖ ·¹°íÄ͹ÙÀÌ¿À ´ëÇ¥ÀÌ»ç´Â ¡°¾ÏÁ¨Àº ¼±µµÀûÀÎ Ç×¾ÏÄ¡·áÁ¦¸¦ ½ÃÀå¿¡ ¼±º¸ÀÌ°í ÀÖ´Â ´ëÇ¥ÀûÀÎ ±Û·Î¹úÁ¦¾à»ç·Î À̹ø Â÷¼¼´ë ADCÄ¡·áÁ¦ °³¹ß¿¡ ´ç»ç ADC±â¼úÀÌ ¼±ÅÃµÇ¾î ¸Å¿ì ±â»Ú´Ù¡±¶ó¸é¼ ¡°À̹ø °è¾àÀ» °è±â·Î ÇâÈÄ ±Û·Î¹úÁ¦¾à»ç Áß½ÉÀ¸·Î ÆÄÆ®³Ê½ÊÀ» È®´ëÇÔ°ú µ¿½Ã¿¡ ÀÚü ADC ÆÄÀÌÇÁ¶óÀεµ °ÈÇÏ¸é¼ ¼ºÀåÀ» °¡¼ÓÈ ÇØ ³ª°¥ °ÍÀÌ´Ù¡±¶ó°í ¸»Çß´Ù. õ½ÂÇö ±âÀÚ(1000@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [»ï¿ø¾àÇ° ¿ï»êÁöÁ¡] °ü¸®¾à»ç´Ô ¸ðÁý°ø°í ¹Ù·Î°¡±â [ÇÏ¿ìÅõ¾à] ºê·£µå/Ç÷§Æû ¿î¿µ Àü·« ±âȹ ¾à»ç ÀÎÅÏ ¸ðÁý ¹Ù·Î°¡±â Sr. Medical Affairs Scientist ¹Ù·Î°¡±â Sr. Clinical Operations Manager ¹Ù·Î°¡±â Market Access Manager ¹Ù·Î°¡±â ¿µ¾÷ / training / compliance / admin ¹Ù·Î°¡±â MSL GM CVT (À°¾ÆÈÞÁ÷´ëü 1³â °è¾àÁ÷) ¹Ù·Î°¡±â PV ±×·ì ¹× ½Ã¼³±×·ì ä¿ë ¹Ù·Î°¡±â 2024 ¾à´ë½ÉȽǽÀ, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â RA, BD, ¿µ¾÷, °øÀå µî ÀüºÎ¹® ä¿ë ¹Ù·Î°¡±â [ºñŸ¹ÎÇϿ콺] ¾à»ç °æ·ÂÁ÷ ä¿ë ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à»ç ä¿ë(Çѱ¹ÀǾàÇ°¾ÈÀü°ü¸®¿ø 24³â 3Â÷ ä¿ë) ¹Ù·Î°¡±â MSL Radiology ¹Ù·Î°¡±â [Çѱ¹¿ÀÃ÷Ä«Á¦¾à] Clinical Trial Manager(1~3»ó) ¹Ù·Î°¡±â (´ëÀü/Ãæû) ¿µ¾÷ºÎ °æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â [¾Ëº¸Á¨ÄÚ¸®¾Æ] Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â º¹»ê³ªÀ̽º ºÎ»ê°ü¸®¾à»ç (ºÎ»êÅëÇÕ¹°·ù¼¾ÅÍ) ¹Ù·Î°¡±â ¿ø·áÀǾàÇ° µµ¸Å, ¼öÀÔ°ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â ȯÀÎÁ¦¾à(ÁÖ) 5¿ù ¼ö½Ãä¿ë(5/7(¿ù)~5/27(¿ù) 13:30±îÁö) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ·¹°íÄÍ, ¾ÏÁ¨¿¡ ½Å¾à Ç÷§Æû ±â¼úÀÌÀü...ÃÖ´ë 1.6Á¶¿ø URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ·¹°íÄÍ, ¾ÏÁ¨¿¡ ½Å¾à Ç÷§Æû ±â¼úÀÌÀü...ÃÖ´ë 1.6Á¶¿ø ±â»çÀÔ·Â : 22.12.23 07:56:13 0 °¡ ÇÃÄ£Ãß°¡ ADC Ç÷§Æû ±â¼ú 5°³ Ÿ±ê Ä¡·áÁ¦ ±ÇÇÑ ÀÌÀü...°è¾à±Ý ºñ°ø [µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] ·¹°íÄ͹ÙÀÌ¿À»çÀ̾𽺴 ±Û·Î¹úÁ¦¾à»ç ¾ÏÁ¨°ú Ç×ü ¾à¹° º¹ÇÕÁ¦(ADC) Ç÷§Æû ±â¼úÀ» ±â¼úÀÌÀüÇß´Ù°í 23ÀÏ °ø½ÃÇß´Ù. À̹ø °è¾àÀ» ÅëÇØ ·¹°íÄ͹ÙÀÌ¿À´Â ±â¼úÀÌ¿ë·á, Àӻ󰳹ߡ¤Çã°¡, »ó¾÷È ¸¶ÀϽºÅæÀ» Æ÷ÇÔÇØ ÃÖ´ë1¾ï2475¸¸´Þ·¯(1Á¶6050¾ï¿ø)°ú ¸ÅÃâ¾×¿¡ µû¸¥ º°µµÀÇ ·Î¿Æ¼¸¦ ¹Þ°Ô µÈ´Ù. °è¾à±Ý ±Ô¸ð´Â °ø°³µÇÁö ¾Ê¾Ò´Ù. ¾ÏÁ¨Àº ÀÚü º¸À¯ Ç×ü¿Í ·¹°íÄ͹ÙÀÌ¿ÀÀÇ Â÷¼¼´ë ADCÇ÷§Æû ±â¼úÀ» È°¿ëÇØ 5°³ Ÿ±ê ´ë»ó ADCÄ¡·áÁ¦ÀÇ ±Û·Î¹ú °³¹ß°ú »ó¾÷È ±Ç¸®¸¦ °®´Â´Ù. ¾ÏÁ¨¿¡ ÀÌÀüµÈ ·¹°íÄ͹ÙÀÌ¿ÀÀÇ ÀÓ»ó´Ü°è ADCÇ÷§Æû ±â¼úÀº ¾Ï¼¼Æ÷ ³»¿¡¼ ¼±ÅÃÀûÀ¸·Î È°¼ºÈµÇ°í Ç×üÀÇ Æ¯Á¤ºÎÀ§ Á¢ÇÕ¿¡ ÃÖÀûÈµÈ °áÇÕ¹æ¹ýÀ¸·Î ±¸¼ºµÈ ±â¼úÀÌ´Ù. ±âÁ¸ ±â¼ú ´ëºñ ³ôÀº È¿´É°ú ³·Àº ºÎÀÛ¿ë ±×¸®°í Ź¿ùÇÑ Ç÷Áß ¾ÈÁ¤¼º µîÀÇ Â÷º°ÈµÈ ÀåÁ¡À» º¸À¯Çß´Ù´Â Æò°¡´Ù. ±è¿ëÁÖ ·¹°íÄ͹ÙÀÌ¿À ´ëÇ¥ÀÌ»ç´Â ¡°¾ÏÁ¨Àº ¼±µµÀûÀÎ Ç×¾ÏÄ¡·áÁ¦¸¦ ½ÃÀå¿¡ ¼±º¸ÀÌ°í ÀÖ´Â ´ëÇ¥ÀûÀÎ ±Û·Î¹úÁ¦¾à»ç·Î À̹ø Â÷¼¼´ë ADCÄ¡·áÁ¦ °³¹ß¿¡ ´ç»ç ADC±â¼úÀÌ ¼±ÅÃµÇ¾î ¸Å¿ì ±â»Ú´Ù¡±¶ó¸é¼ ¡°À̹ø °è¾àÀ» °è±â·Î ÇâÈÄ ±Û·Î¹úÁ¦¾à»ç Áß½ÉÀ¸·Î ÆÄÆ®³Ê½ÊÀ» È®´ëÇÔ°ú µ¿½Ã¿¡ ÀÚü ADC ÆÄÀÌÇÁ¶óÀεµ °ÈÇÏ¸é¼ ¼ºÀåÀ» °¡¼ÓÈ ÇØ ³ª°¥ °ÍÀÌ´Ù¡±¶ó°í ¸»Çß´Ù. õ½ÂÇö ±âÀÚ(1000@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ·¹°íÄÍ, ¾ÏÁ¨¿¡ ½Å¾à Ç÷§Æû ±â¼úÀÌÀü...ÃÖ´ë 1.6Á¶¿ø URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö